GPN Vaccines, Inc.
Total raised
$4 M
1 round on record
Latest round
$4 M
Dec 2025
First round on record
Dec 2025
Today
Private
No later event on record
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2025 | $4 M | No. 1 | $2 to $10 million | equity, options | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
GPN Vaccines, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2026).
SEC Form D · Jan 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jan 2026
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of GPN Vaccines, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| James Selkirk | Executive officer | Jan 2026 |
| Timothy Hirst | Executive officer | Jan 2026 |
| Timothy Hirst | Director | Jan 2026 |